| 2024-05-14 | Sale | Bio-Techne Corporation TECH | director | 4,000 0.0025% | $83.84 | $335,377 | -7.89% | |
| 2023-05-23 | Sale | OmniAb, Inc. OABI | director | 9,000 0.0085% | $4.05 | $36,450 | +19.95% | |
| 2023-05-19 | Sale | OmniAb, Inc. OABI | director | 1,000 0.0011% | $4.05 | $4,050 | +34.2% | |
| 2023-05-18 | Sale | OmniAb, Inc. OABI | director | 50,000 0.05% | $3.89 | $194,500 | +32.02% | |
| 2022-12-16 | Sale | Ligand Pharmaceuticals Incorporated LGND | director | 10,000 0.0585% | $61.87 | $618,657 | +9.29% | |
| 2022-11-17 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Executive Officer | 10,000 0.0593% | $78.32 | $783,173 | -11.04% | |
| 2022-08-10 | Sale | Bio-Techne Corporation TECH | 100 0.0003% | $374.89 | $37,490 | -14.58% | ||
| 2022-06-07 | Sale | Bio-Techne Corporation TECH | 1,000 0.0025% | $364.31 | $364,310 | -10.27% | ||
| 2020-11-06 | Sale | Bio-Techne Corporation TECH | director | 5,000 0.0128% | $300.35 | $1.5M | +37.99% | |
| 2020-02-12 | Sale | Bio-Techne Corporation TECH | director | 10,000 0.0261% | $205.23 | $2.05M | +27.98% | |
| 2019-06-04 | Sale | Bio-Techne Corporation TECH | director | 10,000 0.0264% | $203.67 | $2.04M | +2.03% | |
| 2018-08-30 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Executive Officer | 3,500 0.0166% | $258.25 | $903,875 | -52.06% | |
| 2018-08-23 | Sale | Bio-Techne Corporation TECH | director | 20,000 0.0442% | $156.48 | $3.13M | +3.5% | |
| 2018-08-17 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Executive Officer | 12,993 0.0602% | $243.00 | $3.16M | -49.81% | |
| 2018-08-16 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Executive Officer | 21,507 0.1024% | $241.33 | $5.19M | -48% | |
| 2018-05-15 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Executive Officer | 12,405 0.0051% | $16.14 | $200,217 | -13.7% | |
| 2018-02-15 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Executive Officer | 9,000 0.0424% | $157.03 | $1.41M | +8.91% | |
| 2018-01-24 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Executive Officer | 22,500 0.1069% | $165.00 | $3.71M | +4.52% | |
| 2018-01-19 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Executive Officer | 28,099 0.0624% | $73.40 | $2.06M | +9.87% | |
| 2017-11-17 | Sale | Ligand Pharmaceuticals Incorporated LGND | Chief Executive Officer | 2,258 0.0107% | $140.34 | $316,888 | +22.01% |